Skip to content

Study · Not a test of the peptide alone · 2000

1 result

Species-dependent pharmacological properties of the melanocortin-5 receptor.

Huang RR, Singh G, Van der Ploeg LH, Fong TM

Journal of receptor and signal transduction research1 Jan 2000Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Melanotan II.

  1. 01LabNot a test of Melanotan II aloneIn vitro (cells)Activity measurement

    In CHO cells, several melanocortin peptides including MT-II were more than 10-fold more potent at the rhesus than at the human melanocortin-5 receptor.

    In plain wordsIn cells, several peptides, including melanotan II, were over 10 times more potent at the monkey receptor than at the human receptor.

    Outcome
    Not applicablePotency at rhesus versus human melanocortin-5 receptor
    Study

    rhesus monkey and humann: not reported in source

    CHO cells expressing rhesus or human melanocortin-5 receptor
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    Potency ratio, rhesus versus human MC5R
    > 10 fold
    several peptides including MT-II

    Source sentences

    Summary
    Several peptides including NDP-alpha-MSH, alpha-MSH, MT-II and ACTH1-24 are more potent at the rhesus melanocortin-5 receptor than the human melanocortin-5 receptor by more than 10-fold.
    1 context sentence
    Summary · context
    Heterologous expression in CHO cells indicated species dependent in vitro pharmacological properties for the human and rhesus melanocortin-5 receptors.

    In this study, Melanotan II was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan II.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.